Mirae Asset Global Investments Co., Ltd. Ani Pharmaceuticals Inc Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 836 shares of ANIP stock, worth $55,460. This represents 0.0% of its overall portfolio holdings.
Number of Shares
836
Previous 722
15.79%
Holding current value
$55,460
Previous $48,000
12.5%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ANIP
# of Institutions
239Shares Held
19.9MCall Options Held
7.4KPut Options Held
12.4K-
Black Rock Inc. New York, NY2.66MShares$176 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.18MShares$78.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny818KShares$54.3 Million0.03% of portfolio
-
Global Alpha Capital Management Ltd.736KShares$48.8 Million3.53% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il723KShares$48 Million0.01% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.16B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...